Submission + - Can Red-Light Therapy Treat Brain Injuries? (nytimes.com)
An anonymous reader writes: The knife, the call, the diagnosis in 2013, would lead him on a life-changing mission — one in which he and a team of researchers at the University of Utah would eventually compile research that one of those researchers, Elisabeth Wilde, Ph.D, co-director of the Traumatic Brain Injury (TBI) and Concussion Center, calls “striking.” The treatment they are studying is called photobiomodulation therapy, or itPBM (intranasal transcranial PBM), also known as red-light therapy. It is different from the kind of superficial red-light usage one can find on social media skincare channels or at a wellness boutique, and its application is broader.
The research includes multiple studies, and is not just focused on ex-football players, but on women and men in various walks of life. The group recently published their latest results in the Journal of Neurotrauma, based on a study that followed 26 BYU football players throughout a season, suggesting the treatment could “potentially safeguard neurological health without reduced playing time or contact exposure.”
Definitive clinical trials haven’t been run yet; broader research and validation is required, and some in the field are skeptical. Carr acknowledges some have told him that it could be “too good to be true.” Still, other outside experts who spoke with The Athletic call the findings promising. They make sure to caution: This is not a cure-all, and there is much more to be tested. But the findings have been compelling enough to justify more research and more speculation.
The research includes multiple studies, and is not just focused on ex-football players, but on women and men in various walks of life. The group recently published their latest results in the Journal of Neurotrauma, based on a study that followed 26 BYU football players throughout a season, suggesting the treatment could “potentially safeguard neurological health without reduced playing time or contact exposure.”
Definitive clinical trials haven’t been run yet; broader research and validation is required, and some in the field are skeptical. Carr acknowledges some have told him that it could be “too good to be true.” Still, other outside experts who spoke with The Athletic call the findings promising. They make sure to caution: This is not a cure-all, and there is much more to be tested. But the findings have been compelling enough to justify more research and more speculation.